Oklahoma lawmaker proposes Schedule I action on 7-OH-related compounds

Why it matters

The proposal would shape how Oklahoma regulates concentrated and synthetically enhanced kratom-related compounds, while the underlying legislation has not yet been filed or enacted.

The big picture

The announcement follows broader federal and state scrutiny of concentrated 7-OH-related products. It is a legislative proposal, not a change to Oklahoma law, and the release attributes its mortality figures to the Oklahoma Office of the Chief Medical Examiner.

Key findings

• Rep. Tim Turner said he plans to seek Schedule I placement under Oklahoma law for 7-OH, mitragynine pseudoindoxyl, and dihydro-7-hydroxymitragynine (MGM-15).
• The Oklahoma House release says the bill-introduction deadline for the 2027 session is January 14, with session beginning February 1.
• According to the release, OCME reported 38 deaths involving one identified compound alone from January through June 2026 and 73 more involving at least one compound with another intoxicating substance.
• The release says Turner is working with law-enforcement officials and prosecutors to develop the proposal.
• The release also says current state law limits the Oklahoma Bureau of Narcotics' ability to investigate suppliers of synthetically enhanced products.

What they say

Oklahoma Bureau of Narcotics Director Donnie Anderson said: “Because these products are not listed as Controlled Dangerous Substances in Oklahoma, we currently do not have jurisdiction to investigate and shut down the suppliers.”

Bottom line

**Oklahoma has not changed its law yet, but a state representative has announced a proposal targeting specific concentrated and synthetic kratom-related compounds for the 2027 session.**